We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Risk Factors for Contrast-Induced Nephrotoxicity Debated

By HospiMedica International staff writers
Posted on 18 May 2012
Conflicting with current belief, a new study finds that patients with a history of diabetes are not one of the most at risk for contrast-induced nephrotoxicity. More...
Instead, the study revealed that patients with a history of renal disease, hypertension, and/or heart disease are more likely to suffer from renal insufficiency, putting them at greater risk for contrast-induced nephrotoxicity.

The study, conducted at Northwestern Memorial Hospital-Northwestern University (Chicago, IL, USA), included 2,404 patients. All patients underwent an estimated glomerular filtration rate (eGFR) test immediately before undergoing a CT examination. “Since all patients underwent the eGFR test, we had an unusual opportunity to see if the traditional risk factors truly predict reduced renal function,” said Vahid Yaghmai, MD, one of the authors of the study.

The investigators found, “patients with history of renal disease, hypertension, and heart disease had significantly higher odds of having abnormal eGFR,” said Dr. Yaghmai. That was not the case for patients with diabetes, he said.

Many facilities request that patients to fill out a survey to help determine if the patients are at risk for contrast-induced nephropathy, according to Dr. Yaghmai. Based on the survey results, patients most at risk undergo a test to measure their renal function. “Measuring eGFR right before the CT scan can help us more accurately determine at-risk patients. Our results suggest that history of diabetes is not independent predictors of having reduced renal function,” noted Dr. Yaghmai.

The study was presented May 1, 2012, during the 2012 American Roentgen Ray Society (ARRS) annual meeting in Vancouver (BC, Canada).

Related Links:

Northwestern Memorial Hospital-Northwestern University




New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Rapid Sepsis Test
SeptiCyte RAPID
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Cedit: Shutterstock

New Light-Activated Platform Advances Glioblastoma Surgery and Postoperative Treatment

Glioblastoma, an aggressive primary brain tumor, infiltrates healthy tissue and resists complete surgical removal. Residual microscopic disease and the blood–brain barrier limit the effectiveness of adjuvant... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.